OBP Management IV LP
CIK 0001286541 Name as filed on the most recent filing
Filed as OBP Management IV LP (9)
23 transaction lines · from 9 filings · filed 2004-06-04 to 2006-10-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Cyberkinetics Neurotechnology Systems, Inc. 3 filings
- ISSUER Trubion Pharmaceuticals, Inc 1 filings
- ISSUER Solexa, Inc. 1 filings
- ISSUER Acadia Pharmaceuticals Inc 2 filings
- ISSUER Imcor Pharmaceutical Co 2 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2006-10-18 |
Cyberkinetics Neurotechnology Systems, Inc. CYKN |
P, Open-market purchase | 825,056 acquired | 1.20 | 990,067.20 | Form 4, filing 0001012975-06-000417 | |
| 2006-10-18 |
Cyberkinetics Neurotechnology Systems, Inc. CYKN |
P, Open-market purchase | 8,278 acquired | 1.20 | 9,933.60 | Form 4, filing 0001012975-06-000417 | |
| 2006-10-17 |
Trubion Pharmaceuticals, Inc TRBN |
P, Open-market purchase | 41,201 acquired | 13.00 | 535,613.00 | Form 4, filing 0001012975-06-000412 | |
| 2006-10-17 |
Trubion Pharmaceuticals, Inc TRBN |
P, Open-market purchase | 413 acquired | 13.00 | 5,369.00 | Form 4, filing 0001012975-06-000412 | |
| 2005-09-26 |
Cyberkinetics Neurotechnology Systems, Inc. CYKN |
P, Open-market purchase | 2,475,166 acquired | 1.20 | 2,970,199.20 | Form 4, filing 0001012975-05-000312 | |
| 2005-09-26 |
Cyberkinetics Neurotechnology Systems, Inc. CYKN |
P, Open-market purchase | 24,834 acquired | 1.20 | 29,800.80 | Form 4, filing 0001012975-05-000312 | |
| 2005-07-12 |
Solexa, Inc. SLXA |
P, Open-market purchase | 544,536 acquired | 4.00 | 2,178,144.00 | Form 4, filing 0001140484-05-000017 | |
| 2005-07-12 |
Solexa, Inc. SLXA |
P, Open-market purchase | 5,464 acquired | 4.00 | 21,856.00 | Form 4, filing 0001140484-05-000017 | |
| 2005-04-20 |
Acadia Pharmaceuticals Inc ACAD |
P, Open-market purchase | 586,402 acquired | 6.82 | 4,000,023.96 | Form 4, filing 0001140484-05-000010 | |
| 2004-11-04 |
Cyberkinetics Neurotechnology Systems, Inc. CYKN |
P, Open-market purchase | 315,337 acquired | 3.00 | 946,011.00 | Form 4, filing 0001286962-04-000009 | |
| 2004-11-04 |
Cyberkinetics Neurotechnology Systems, Inc. CYKN |
P, Open-market purchase | 3,164 acquired | 3.00 | 9,492.00 | Form 4, filing 0001286962-04-000009 | |
| 2004-06-02 |
Acadia Pharmaceuticals Inc ACAD |
P, Open-market purchase | 282,169 acquired | 7.00 | 1,975,183.00 | Form 4, filing 0001179044-04-000119 | |
| 2004-06-02 |
Acadia Pharmaceuticals Inc ACAD |
P, Open-market purchase | 2,831 acquired | 7.00 | 19,817.00 | Form 4, filing 0001179044-04-000119 | |
| 2004-04-19 |
Imcor Pharmaceutical Co ICPHC |
P, Open-market purchase | 22,022,417 acquired | 0.40 | 8,808,966.80 | Form 4, filing 0001181431-04-034055 | |
| 2004-04-19 |
Imcor Pharmaceutical Co ICPHC |
S, Open-market sale | 8,800,966.96 disposed | 0.40 | 3,520,386.78 | Form 4, filing 0001181431-04-034055 | |
| 2004-04-19 |
Imcor Pharmaceutical Co ICPHC |
S, Open-market sale | 8,770,415.43 disposed | 0.75 | 6,577,811.57 | Form 4, filing 0001181431-04-031293 | |
| 2004-04-19 |
Imcor Pharmaceutical Co ICPHC |
P, Open-market purchase | 11,693,887 acquired | 0.75 | 8,770,415.25 | Form 4, filing 0001181431-04-031293 | |
| 2004-04-14 |
Imcor Pharmaceutical Co ICPHC |
P, Open-market purchase | 5,500,000 acquired | 0.40 | 2,200,000.00 | Form 4, filing 0001181431-04-034055 | |
| 2004-04-14 |
Imcor Pharmaceutical Co ICPHC |
P, Open-market purchase | 9,750,870 acquired | 0.40 | 3,900,348.00 | Form 4, filing 0001181431-04-034055 | |
| 2004-04-14 |
Imcor Pharmaceutical Co ICPHC |
S, Open-market sale | 3,900,348 disposed | 0.40 | 1,560,139.20 | Form 4, filing 0001181431-04-034055 | |
| 2004-04-14 |
Imcor Pharmaceutical Co ICPHC |
S, Open-market sale | 3,900,348 disposed | 0.75 | 2,925,261.00 | Form 4, filing 0001181431-04-031293 | |
| 2004-04-14 |
Imcor Pharmaceutical Co ICPHC |
P, Open-market purchase | 5,200,464 acquired | 0.75 | 3,900,348.00 | Form 4, filing 0001181431-04-031293 | |
| 2004-04-14 |
Imcor Pharmaceutical Co ICPHC |
P, Open-market purchase | 2,933,334 acquired | 0.75 | 2,200,000.50 | Form 4, filing 0001181431-04-031293 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. OBP MANAGEMENT IV LP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001286541
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6